会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • DETECTION AND TREATMENT OF MICROSPORIDIAN INFECTION
    • 微小隐孢子虫感染的检测与治疗
    • WO2018051071A1
    • 2018-03-22
    • PCT/GB2017/052676
    • 2017-09-12
    • BENCHMARK ANIMAL HEALTH LIMITED
    • SCHOLZ, FelixRODGER, Hamish
    • A61K39/395C12Q1/68C12N15/11G01N33/53
    • G01N33/56961A61K39/00A61K2039/552C12Q1/6895G01N2500/10
    • An isolated or synthetic nucleic acid from having a sequence selected from the group consisting of SEQ ID NOs: 9, 13 and 1-8, or a homologues thereof, an isolated or synthetic nucleic acid complementary to a sequence selected from the group consisting of SEQ ID NOs: 1-14, or a homologues thereof, an isolated polypeptide encoded by the nucleic acid, or an antibody that binds thereto, may be used as an immunogenic composition or diagnostic, or in a method of treatment or prevention, in respect of a microsporidian infection, in particular a Tetramicra brevifilum infection in animals, particularly fish. Additionally, methods of testing an agent for the prevention and/or treatment of a microsporidian infection, preferably a Tetramicra brevifilum infection, and kits for screening for a microsporidian infection, are provided.
    • 具有选自SEQ ID NO:9,13和1-8的序列的分离的或合成的核酸,或其同源物,分离的或合成的核酸,其与 选自SEQ ID NO:1-14的序列或其同源物,由该核酸编码的分离的多肽或与其结合的抗体可以用作免疫原性组合物或诊断剂,或在方法中 对微孢子虫感染,特别是在动物特别是鱼类中感染的Tetramicra brevifilum感染的治疗或预防。 此外,还提供了用于预防和/或治疗微孢子虫感染的试剂的方法,优选地为Tetramicra brevifilum感染,以及用于筛选微孢子虫感染的试剂盒。
    • 6. 发明申请
    • TREATMENT. OF MARINE PARASITE INFECTION
    • 治疗。 海洋寄生虫感染
    • WO2017216541A1
    • 2017-12-21
    • PCT/GB2017/051715
    • 2017-06-13
    • BENCHMARK ANIMAL HEALTH LIMITED
    • REILLY, RobertMARSHALL, John
    • A01N57/16A01N51/00A01N25/00A01P1/00
    • A01N57/16A01N25/00A01N51/00
    • A combination of an anti-parasitic agent, such as azamethiphos, and fresh water for use in the treatment or prevention of a marine parasite infection in a fish, wherein the use is sequential, separate and/or simultaneous. Typically, the use is sequential, and the anti- parasitic agent is applied after an initial period in the fresh water. The treatment is suitable for a variety of fish, for example Salmo salar , sea bass, sea bream, and is effective against parasitic infections such as those mediated by Lepeophtheirus salmonis , Caligus rogercresseyi , Caligus clemensi and amoebic gill disease, The combination also provides methods of enhancing the effectiveness of an anti-marine parasitic agent, reducing the resistance of marine parasites to an anti-marine parasitic agent, treating a marine parasite infection in a fish, and preventing re-infection of a fish with a marine parasite.
    • 用于治疗或预防鱼类中的海生寄生虫感染的抗寄生虫剂如阿美利西泊(azamethiphos)和淡水的组合,其中所述用途是连续的,分开的和/或 同时。 典型地,使用是顺序的,并且在淡水中的初始阶段之后应用抗寄生虫剂。 该处理适用于各种鱼类,例如Salmo salar,鲈鱼,鲷鱼,并且对寄生虫感染例如由鲑鱼疮疱病毒介导的寄生虫感染是有效的, Caligus rogercresseyi,Caligus clemensi和阿米巴鳃疾病,该组合还提供了增强抗海洋寄生物剂的有效性的方法,其降低了抗性 将海洋寄生虫转化为抗海洋寄生虫剂,治疗鱼类中的海洋寄生虫感染,以及防止海洋寄生虫再次感染鱼类。